Popular Articles

Shire Receives Fast Track Designation For Velaglucerase Alfa For Gaucher Disease
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Type I Gaucher disease. Shire is working with the FDA to determine subsequent steps and timing for the filing of its NDA.
generic viagra online
Afghani Children Suffering From Post Traumatic Stress
Children who live in Afghanistan are particularly affected every day by a multitude of war time stressors which increase the likelihood of developing PTSD: trauma, child labor, and family and military violence. On a daily basis they are first-hand witnesses to the bombings, abuse, and the general upheaval of their home life and society as a result of war, including the effects of long-term poverty and familial turmoil.
News of the day
Despite Decreases In Appetite And Consumption, Sleep Restriction Results In Weight Gain
According to a research abstract presented on June 8 at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, in the presence of free access to food, sleep restricted subjects reported decrease in appetite, food cravings and food consumption; however, they gained weight over the course of the study. Thus, the finding suggests that energy intake exceeded energy expenditure during the sleep restriction
Nutrition

Why Smoking Increases The Risk Of Heart Disease And Strokes

Researchers at Charles Drew University of Medicine and Science in Los Angeles and Western University of Health Sciences in Pomona have discovered a reason why smoking increases the risk of heart disease and strokes. The study, which was presented at The Endocrine Society"s 91st annual meeting in Washington, D.C., found that nicotine in cigarettes promotes insulin resistance, a pre-diabetic condition that raises blood sugar levels higher than normal. People with pre-diabetes are at greater risk of developing cardiovascular disease. Theodore Friedman, MD, Ph.D., chief of the endocrinology division at Charles Drew University, said the findings help explain a "paradox" that links smoking to heart disease. Smokers experience a high degree of cardiovascular deaths, Friedman said. "This is surprising considering both smoking and nicotine may cause weight loss and weight loss should protect against cardiovascular disease." The researchers studied the effects of twice-daily injections of nicotine on 24 adult mice over two weeks. The nicotine-injected mice ate less food, lost weight and had less fat than control mice that received injections without nicotine. "Our results in mice show that nicotine administration leads to both weight loss and decreased food intake," Friedman said. "Mice exposed to nicotine have less fat. In spite of this, mice have abnormal glucose tolerance and are insulin resistant (pre-diabetes)." Studies have shown that smokers who are pre-diabetic have blood glucose levels higher than normal, but not high enough for diabetes, a known risk factor for heart disease. Smokers also have higher rates of diabetes, but it is not directly clear whether smoking is the cause, because there could be other risk factors, Friedman said. In the tests, however, the mice receiving nicotine developed pre-diabetes and also had high levels of the stress hormone cortisol, which increases blood pressure and blood sugar. The study"s authors were able to partially reverse the harmful effects of pre-diabetes by treating the mice with a drug that blunts the action of nicotine. "Our results suggest that decreasing insulin resistance may reduce the heart disease seen in smokers," Friedman said. "We anticipate that in the future there will be drugs to specifically block the effect of nicotine on insulin resistance." New drugs are needed because those that are currently available are not specific enough to completely block nicotine"s effects or they have bothersome side effects, said Friedman, whose study is one of 34 featured at The Endocrine Society"s 91st annual meeting.. John L. Mitchell Charles Drew University of Medicine and Science


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):